Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Gichuhi, Stephen ^a   Irlam, J J H ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Carcinoma, squamous cell *therapy ; Conjunctival neoplasms *therapy ; HIV infections *complications

Indexed keywords

ALPHA2B INTERFERON; ANTIRETROVIRUS AGENT; CIDOFOVIR; FLUOROURACIL; INTERFERON; MITOMYCIN C; PLACEBO;

AMNION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; CONJUNCTIVAL SQUAMOUS CELL CARCINOMA; CONTROLLED CLINICAL TRIAL; CRYOTHERAPY; ENUCLEATION; EVISCERATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 44949216635     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005643.pub2     Document Type: Review

References (64)

1. Ateenyi Agaba
2. Decensi
3. Grossniklaus
4. Helal
5. Karcioglu
6. Kestelyn
7. Muccioli
8. Newton
9. Seregard
10. Smith
11. Tornesello
12. Waddell
13. Aoki 1998 Aoki S, Kubo E, Nakamura S, Tsuzuki A, Tsuzuki S, Takahashi Y, et al.Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma. Japanese Journal of Ophthalmology 1998;42(4):256-61.
14. Ateenyi-Agaba 1995 Ateenyi-Agaba C. Conjunctival squamous cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 1995;345(8951):695-6.
15. Ateenyi-Agaba 2004a Ateenyi-Agaba C, Dai M, Le Calvez F, Katongole-Mbidde E, Smet A, Tommasino M, et al. TP53 mutations in squamous cell carcinomas of the conjuntiva: evidence for UV-induced mutagenesis. Mutagenesis 2004;19(5):399-401.
16. Ateenyi-Agaba 2004b Ateenyi-Agaba C, Weiderpass E, Smet A, Dong W, Dai M, Kahwa B, et al.Epidermodysplasia verucciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot case-control study in Uganda. British Journal of Cancer 2004;90(9):1777-9.
17. Atkins 2004 Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.Grading quality of evidence and strengths of recommendations. BMJ 2004;328(7454):1490-7.
18. Barbazetto 2004 Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. American Journal of Ophthalmology 2004;138(2):183-9.
19. Basti 2003 Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea 2003;22(7):687-704.
20. Cartsburg 2001 Cartsburg O, Kallen C, Hillenkamp J, Sundmacher R, Pomjanski N, Bocking A. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. Analytical Cellular Pathology 2001;23(2):65-74.
21. Castano 2005 Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis and Photodynamic Therapy 2005;2(2):91-106.
22. Cerezo 1990 Cerezo L, Otero J, Aragon G, Polo E, de la Torre A, Valcarcel F, et al.Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90. Radiotherapy and oncology Journal of the European Society for Therapeutic Radiology and Oncology 1990;17(3):191-7.
23. Cervantes 2002 Cervantes G, Rodriguez AA Jr, Leal AG. Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Canadian Journal of Ophthalmology 2002;37(1):14-9.
24. Chisi 2006 Chisi SK, Kollmann MKH, Karimurio J. Conjunctival squamous cell carcinoma in patients with Human Immunodeficiency Virus infection seen at two hospitals in Kenya. East African Medical Journal 2006;83(5):267-70.
25. Chu 2004 Chu T, Sartorelli AC. Cancer chemotherapy. In: KatzungBG editor (s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:898-930.
26. Clifford 2005 Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJF, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366(9490): 991-8.
27. Copeland 1990 Copeland RA. Limbal autograft for reconstruction after conjunctival squamous cell carcinoma. American Journal of Ophthalmology 1990;4(110):412-5.
28. Espana 2002 Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SCG. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. British Journal of Ophthalmology 2002;86(6):640-5.
29. Frucht-Pery 1997 Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, et al.Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997;104(12):2085-93.
30. Goldberg 1963 Goldberg JR, Becker SC, Rosenbaum HD. Gamma radiation in the treatment of squamous cell carcinoma of the limbus. American Journal of Ophthalmology 1963;55:811-5.
31. Gunduz 2005 Gunduz K, Ucakhan OO, Kanpolat A, Gunalp I. Non-preserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 2005;20(3):351-7.
32. Hao 2000 Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19(3):348-52.
33. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005). www.cochrane.org/resources/handbook/hbook.htm (accessed 21st February 2006).
34. Kaji 2006 Kaji Y, Hiraoka T, Oshika T. Vital staining of squamous cell carcinoma of the conjunctiva using toluidine blue. Acta Ophthalmologica Scandinavica 2006;84(6):825-6.
35. Karp 2001 Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 2001;108(6):1093-8.
36. Lake 2004 Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: KatzungBG editor(s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:931-57.
37. Lee 1997 Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Australian and New Zealand Journal of Ophthalmology 1997;25(4):269-76.
38. Macarez 1999 Macarez R, Bossis S, Robinet A, Le Callonnec A, Charlin JF, Colin J. Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy. Cornea 1999;18(4):495-7.
39. Mahomed 2002 Mahomed A, Chetty R. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Archives of Ophthalmology 2002;120(5):554-8.
40. Margo 2002 Margo CE, Harman LE, Mulla ZD. The reliability of clinical methods in ophthalmology. Survey of Ophthalmology 2002;47(4):375-86.
41. McKelvie 2001 McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. British Journal of Ophthalmology 2001;85(9):1115-9.
42. McKelvie 2002 McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. British Journal of Ophthalmology 2002;86(2):168-73.
43. Midena 2000 Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. British Journal of Ophthalmology 2000;84(3):268- 72.
44. Nadjari 1999 Nadjari B, Kersten A, Ross B, Motherby H, Krallmann R, Sundmacher R, et al.Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva. Analytical and Quantitative Cytology and Histology 1999;21(5):387-96.
45. Nakamura 1997 Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation and polymerase chain reaction. British Journal of Ophthalmology 1997;81(4):308-13.
46. Newton 2002 Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, et al.The epidemiology of conjunctival squamous cell carcinoma in Uganda. British Journal of Cancer 2002;87(3):301-8.
47. NIH 2006 U.S. National Institutes of Health. Information on clinical trials and human research studies. www.clinicaltrials.gov (accessed 15 June 2006).
48. Peksayar 1989 Peksayar G, Soyturk MK, Demiryont M. Long-term results of cryotherapy on malignant epithelial tumours of the conjunctiva. American Journal of Ophthalmology 1989;107(4):337-49.
49. Phillips 2001 Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al.Levels of evidence and grades of recommendation. www.cebm.net/levels_of_evidence.asp (accessed 14 June 2006).
50. Pola 2003 Pola EC, Masanganise R, Rusakaniko S. The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000. Central African Journal of Medicine 2003;49:1-4.
51. Poole 1999 Poole TR. Conjunctival squamous cell carcinoma in Tanzania. British Journal of Ophthalmology 1999;83(2):177-9.
52. Porges 2003 Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea 2003;22(1):1-4.
53. Safrin 2004 Safrin S. Antiviral agents. In: KatzungBG editor(s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:801-27.
54. Sherman 2002 Sherman MD, Feldman KA, Farahmand SM, Margolis TP. Treatment of conjunctival squamous cell carcinoma with topical cidofovir. American Journal of Ophthalmology 2002;134(3):432-3.
55. Shields 1991 Shields JA, Shields CL, Suvarnamani C, Tantisira M, Shah P. Orbital exenteration with eyelid sparing: indications, technique and results. Ophthalmic surgery 1991;22(5):292-7.
56. Shields 1997 Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumours: The 1994 Lynn B. McMahan Lecture. Archives of Ophthalmology 1997;115(6):808-15.
57. Shields 2004 Shields JA, Shields CL. Tumors of the conjunctiva and cornea. In: McLeod SD editor In: TasmanW, JaegerEA editor(s). Duane's clinical ophthalmology CD-ROM. Revised 2004. Vol. 4, Philadelphia: Lippincott William and Wilkins, 2004:Chapter 10.
58. Sudesh 2000 Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC Jr, Laibson PR. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 2000;19(3):278-83.
59. Tabin 1997 Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival neoplasia. Ophthalmology 1997;104(3):485-92.
60. Tornesello 2006 Tornesello ML, Duraturo ML, Waddell KM, Biryahwaho B, Downing R, Balinandi S, et al.Evaluating the role of human papillomaviruses in conjunctival neoplasia. British Journal of Cancer 2006;94(3): 446-9.
61. Tunc 1999 Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. British Journal of Ophthalmology 1999;83(1):98-103.
62. UNAIDS 2006 UNAIDS. 2006 Report on the global AIDS epidemic. www.unaids.org/en/HIV_data/2006GlobalReport/ (accessed 9th June 2006).
63. Waddell 1996 Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. British Journal of Ophthalmology 1996;80(6): 503-8.
64. Yeatts 2000 Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walker KA. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 2000;107(12):2190-5.